NCT03688685: A reported trial by Cadent Therapeutics
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03688685 |
|---|---|
| Title | A Phase 2a Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of CAD-1883 Oral Treatment in Adults With Essential Tremor |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 23, 2019 |
| Completion date | Sept. 10, 2019 |
| Required reporting date | Sept. 10, 2022, midnight |
| Actual reporting date | June 18, 2021 |
| Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
| Days late | None |